Global Neurovascular Devices Market Research Report – Global Forecast Till 2023

$4,450$6,250

Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units) – Global Forecast Till 2023

Clear

Description

Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units) – Global Forecast Till 2023
Market Analysis
For the treatment of neurovascular diseases like arteriovenous malformations (AVMs), brain aneurysm, and others, the neurovascular devices are used. With the expanding worldwide burden of the neurovascular illnesses and rising interest for negligibly invasive systems, the market for neurovascular gadgets was created. The market keeps on developing these reasonable stages. Furthermore, factors, for example, good repayment strategies, and continuous product development and commercialization drive market development. Hence, the global market for neurovascular devices is relied upon to develop at an exponential rate amid the forecast period (2017-2023).
Nevertheless, high procedural expense pursued by revealed instances of damage and the requirement for doctor preparing is assessed to control the market development amid the gauge time frame. It is accounted for that the normal expense for the treatment of neurovascular devices utilizing the flow diversion is assessed to be about USD 24,650. The Global Neurovascular Devices Market is projected to grow at a CAGR of 8.8% during forecast period.
Market Segmentation
The global neurovascular devices market is divided on the basis of product, end-user, therapeutic application, and regional analysis. Based on its product, the market is classified into embolization devices & aneurysm coiling, support device, neuro thrombectomy devices, stenting systems, and cerebral balloon angioplasty. Based on its therapeutic application, the global neurovascular devices market is categorized into ischemic strokes and hemorrhagic stroke. On the basis of the end-users industry, the market is classified into ambulatory surgical units and hospitals & clinics.
Regional Analysis
Geographically, the global neurovascular devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
The industry players for the global neurovascular devices market include companies like Stryker, Johnson & Johnson Services, Inc., Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Penumbra, Inc., Evasc, Neuravi, Rapid Medical, W. L. Gore & Associates, Inc., Sensome, OxfordEndovascular, Blockade Medical, LLC., Secant Group, LLC, Delaware Corporation, Gynesonics, among others.

Table of Contents

Table of Contents:

1 Report Prologue
1.1 Introduction
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.4.1 Assumptions
1.4.2 Limitations
2 Research Methodology
2.1.1 Primary Research Methodology
2.1.2 Secondary Research Methodology
2.1.3 Market Share Analysis
2.1.4 Market Pricing Approach
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Increasing prevalence of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others, will propel the neurovascular devices market
3.2.2 Favourable reimbursement policies provide favorable background for market growth
3.2.3 Rising demands for minimally invasive therapeutic procedures and growing geriatric population will drive the neurovascular devices market growth
3.2.4 Ongoing product development & commercialization will boost the neurovascular devices market
3.3 Restraints
3.3.1 High procedural cost by neurovascular devices
3.3.2 Cases of injury and need for physician training
3.4 Opportunity
3.5 Mega trend
3.5.1.1 Increasing use of endovascular embolization for the treatment of brain aneurysm
3.6 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Value Chain Analysis
4.1.1 R&D and Designing
4.1.2 Manufacturing
4.1.3 Distribution & Sales
4.1.4 Post-Sales Review
4.2 Porter’s Five Forces Model
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitutes
4.2.5 Intensity of Rivalry
4.3 Investment Opportunities
4.4 Pricing Analysis
4.5 Demand & Supply: Gap Analysis
5 Global Neurovascular Devices Market,  By Product
5.1 Introduction
5.1.1 Aneurysm Coiling & Embolization Devices
5.1.1.1 Embolic Coils
5.1.1.1.1 Detachable Coils
5.1.1.1.2 Pushable Coils
5.1.1.2 Flow Diversion Devices
5.1.1.3 Liquid Embolic
5.1.2 Neurothrombectomy Devices
5.1.2.1 Retrieval Systems
5.1.2.2 Suction and Aspiration Devices
5.1.3 Support Device
5.1.3.1 Microcatheters
5.1.3.2 Microguidewires
5.1.4 Cerebral Balloon Angioplasty and Stenting Systems
5.1.4.1 Carotid Artery Stents
5.1.4.2 Embolic Protection Systems
5.1.4.2.1 Balloon Occlusion Devices
5.1.4.2.2 Distal Filter Devices
6 Global Neurovascular Devices Market,  By Therapeutic Application
6.1 Introduction
6.1.1 Hemorrhagic stroke
6.1.2 Ischemic Strokes
7 Global Neurovascular Devices Market,  By End User
7.1 Introduction
7.1.1 Hospitals & Clinics
7.1.2 Ambulatory Surgical Units
8 Global Neurovascular Devices Market,  By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 U.K
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 United Arab Emirates
8.5.2 Saudi Arabia
8.5.3 Oman
8.5.4 Kuwait
8.5.5 Qatar
8.5.6 Rest of Middle East & Africa
9 Company Landscape
9.1 Company Share Analysis
10 Company Profiles
10.1 Stryker
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Products
10.1.4 Strategy
10.1.5 Key Developments
10.2 Medtronic
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Products
10.2.4 Strategy
10.2.5 Key Developments
10.3 Johnson & Johnson Services, Inc
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Products
10.3.4 Strategy
10.3.5 Key Developments
10.4 TERUMO CORPORATION
10.4.1 Company Overview
10.4.2 Financials
10.4.3 Products
10.4.4 Strategy
10.4.5 Key Developments
10.5 Abbott
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Products
10.5.4 Strategy
10.5.5 Key Developments
10.6 Merit Medical Systems, Inc.
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Products
10.6.4 Strategy
10.6.5 Key Developments
10.7 Medikit co., ltd.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Products
10.7.4 Strategy
10.7.5 Key Developments
10.8 Penumbra, Inc.
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Products
10.8.4 Strategy
10.8.5 Key Developments
10.9 MicroPort Scientific Corporatio
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Products
10.9.4 Strategy
10.9.5 Key Developments
10.1 Evasc
10.10.1 Company Overview
10.10.2 Financials
10.10.3 Products
10.10.4 Strategy
10.10.5 Key Developments
10.11 Rapid Medical
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Products
10.11.4 Strategy
10.11.5 Key Developments
11 Conclusion
11.1 Key Findings
11.1.1 CEO’s Viewpoint
11.1.2 Key Companies to Watch
11.1.3 Prediction of NEUROVASCULAR Devices Industry
12 Appendix
12.1 Discussion Blue Print
12.2 References

Additional information

Publisher

Geography Covered

Date Published

Pages

Format